Interestingly, results from the UK Biobank Imputed Version 3 dataset, generated by the Neale Lab [95], support a connection between the same TAS2R variants reported here and non-COVID-19-related respiratory diseases: rs3851584 (G) in TAS2R14 and respiratory disease symptoms (p < 0.001; effect size reported for T allele:−0.054); rs117458236 (T) in TAS2R20 and pulmonary inflammation or edema (p = 0.02; effect size: 1.5); rs2234010 (A) in TAS2R5 and dependence on respirator (p = 0.001; effect size: 0.72). This evidence concerns the gene TAS2R20 and COVID-19.